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A semi-micro assay was developed for the conjugation of Sa,&u-epoxy-cholestan-3/3-ol (cholesterol CY- 
oxide) with glutathione. The soluble supernatant of rat liver homogenate catalysed the reaction at a rate 
of 0.2-0.5 pmol. min-’ . mg protein-’ with 4pM cholesterol a-oxide, while the reaction in the presence of 
GSH alone was barely detectable. Enzymic activity in the soluble supernatant was due equally to the two 
forms of glutathione transferase B (-1OOpmol. min-’ . mg protein-‘), glutathione transferases AA, A, C 
and E being unreactive. The activity of purified glutathione transferase B was about 5-times that expected 
from the activity of the soluble supernatant. Complex enzyme kinetics were obtained suggestive of 
substrate inhibition. 
Glutathione transferase B 
1. INTRODUCTION 
The glutathione transferases (EC 2.5.1.18) are a 
family of enzymes, widely distributed in nature, 
that catalyse the reaction of a variety of electro- 
philes with glutathione (GSH) [l-3]. They have 
numerous suggested functions generally related to 
detoxication or protective mechanisms including 
the intracellular transport of bilirubin and haem, 
the prevention of lipid peroxidation and the con- 
jugation of a variety of reactive carcinogen and 
drug metabolites with GSH [3]. Almost all studies 
of GSH conjugation by these enzymes have been 
concerned with exogeneous compounds, but the re- 
cent discovery of the structure of leukotrienes [4,5] 
shows that GSH conjugation of reactive en- 
dogenous metabolites also occurs. Another possi- 
ble endogenous reactant is 5cu,&-epoxy-cholestan- 
3&01 (cholesterol a-oxide), a possible carcinogen 
[6,7] which is formed during microsomal lipid 
peroxidation [8]. This is converted to the GSH con- 
jugate by the soluble supernatant of rat liver 
homogenate [9]. Here the rat liver GSH transferase 
responsible for the conjugation of cholesterol cy- 
oxide is identified. 
Cholesterol a-oxide substrate 
2. MATERIALS AND METHODS 
[4-14C]Cholesterol (58 mCi/mmol) was obtained 
from Amersham International (Bucks). USP- 
cholesterol from Sigma London Chemical Co. 
(Poole, Dorset) was recrystallised twice from 
ethanol-water. Cholestan-3,&,5~,@‘-trio1 was ob- 
tained from Steraloids (Croydon). Plastic-backed 
silica gel 60 TLC plates were from E. Merck 
(Darmstadt). 
Unlabelled and r4C-labelled ScY,&-epoxychol- 
estan-3,801 were synthesized using m-chloroper- 
benzoic acid [lo] and purified by silica gel TLC 
with diethyl ether as solvent at 4°C [ll]. It was 
stored in toluene at 4’C. [14C]3P,5a-Dihydroxy- 
cholestan-6&S-y1 glutathione was synthesized and 
purified by TLC as in [9]. The compound was 
ninhydrin reactive and yielded a characteristic blue 
spot at 80°C after spraying with 50% HzS04. The 
conjugate was stored in dry butanol at -20°C. 
GSH transferases were purified from rat liver by 
a modification of the method in [12] in which iso- 
electric focusing was carried out between affinity 
chromatography and hydroxylapatite chromato- 
graphy. 
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Assays of the conjugation of cholesterol a-oxide 
with GSH were carried out in 9 x 50 mm test tubes, 
which routinely contained 65~10.1 M K-phosphate 
(pH 7.0) (k GSH transferases) and an appropriate 
amount of substrate added in 3~1 acetone. The 
tubes were shaken gently for 10min at 30°C and 
the reaction initiated by addition of 10~1 
phosphate buffer containing GSH. The reaction 
was stopped by the addition and rapid mixing 
of 6~1 3 N acetic acid together with 0.13 ml wa- 
ter-saturated n-butanol. After centrifugation 
(1000 x g, 10min) a measured portion of the 
butanol extract (routinely 50~1) was analysed by 
TLC on silica gel using ethyl acetate: acetic 
acid : n-butanol :Hz0 (6 : 3 : 2 : 2 v/v) as solvent [9]. 
After drying, the plate was run for twice the 
distance in diethyl ether at 4°C to separate chol- 
estan-3flSa,6,&triol, a hydrolysis product, from 
unreacted cholesterol a-oxide. The GSH con- 
jugate, cholestan-3,&,5a,6,&triol and cholesterol (Y- 
oxide from the reaction mixtures were identified by 
a comparison with standard compounds detected 
separately by charring with 50% HzS04. The three 
components eparated and identified as above were 
transferred to scintillation vials, the GSH con- 
jugate was pretreated with 0.3 ml methanol: 1 N 
NaOH (1 : l), v/v), and radioactivity determined 
using 7 ml of scintillation fluid (10 g 2,5-diphenyl- 
oxazole; 1 g 1,4-di-2-(5-phenyloxazolyl)-benzene, 
500 ml Triton-X-100 and 21 sulphur-free toluene). 
3. RESULTS AND DISCUSSION 
The soluble supernatant of rat liver homogenate 
catalysed the conjugation of GSH with cholesterol 
u-oxide at 0.2-0.5 pmol. min-’ . mg protein-’ 
(table 1) confirming the findings in [9] where an 
assay system was used which also contained 5% 
methanol and 0.025% Tween 80 to solubilise the 
substrate. Purification of the major rat liver GSH 
transferases demonstrated (table 1) that the activity 
present in the soluble fraction was due only to the 
two forms of GSH transferase B, a degree of 
specificity unusual among GSH transferases [131. 
Since the activity is present in transferase B con- 
sisting of YaYa or YaYc subunits but not in 
transferase AA which consists of YcYc subunits 
[15], it seems to be associated with a Ya-type 
subunit. This is in accord with the presence of a 
high affinity hydrophobic binding site on Ya [16] 
Table 1 
GSH conjugation of cholesterol a-oxide by rat liver 
GSH transferases 
(pmol. min-’ . mg protein-‘) 
Enzyme Subunit [GSH] Conjuga- 
compo- (mM) tion rate 
sition 
Dialysed soluble 
supernatant 4 0.2-0.5 
Transferase B YaYa 4 60-l 10 
Transferase B YaYc 4 60-110 
Transferase AA YCYC 4 (< 0.2)’ 
Transferase E b 10 (< 0.2)’ 
Transferase A YbYb 4 (<0.2)’ 
Transferase C YbYb 4 (< 0.2)’ 
a Determined by SDS-polyacrylamide gel elec- 
trophoresis with nomenclature as in [14] 
b The subunit composition of GSH transferase E does 
not correspond exactly with Ya, Yb or Yc 
’ Undetectable 
Assays were carried out as described in the text using a 
10min reaction period and 3-4pM cholesterol a-oxide 
(-lo4 dpm). Detectable rates are the range of 5 or more 
determinations with separate enzyme preparations 
for which cholesterol is a ligand [ 171, and also with 
the specific 5A-3-ketosteroid isomerase activity of 
transferase B. However, unlike steroid isomerase 
activity which is twice as high in YaYa as in YaYc 
[18], the ability to conjugate cholesterol a-oxide 
did not differ significantly between the two forms 
of GSH transferase B, and was more comparable 
with their similar cholesterol-binding activities 
(unpublished). 
Curiously, the activity of the purified enzymes 
was about 7-fold higher than that expected from 
the activity of the whole soluble fraction which 
contains up to 4% of transferase B. This suggests 
that the substrate may be partly unavailable to the 
transferases in the unfractionated sample either 
because the cholesterol a-oxide is sequestered in 
lipoproteins or because ndogenous ligands occupy 
the substrate binding site. No hydrolysis of the 
GSH conjugate to cholestan-3,5,6-trio1 was 
detected in the presence of transferases, the soluble 
supernatant, or the whole rat liver homogenate. 
The time course and concentration dependence 
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Fig. 1. Characterisation of the conjugation of 
cholesterol e-oxide by GSH S-transferase B: (a) time 
course of reaction; (b) dependence upon protein 
concentration, assays contained 4,uM cholesterol (Y- 
oxide; (c) dependence on concentration of cholesterol cy- 
oxide, assays contained 25pg transferase B and were 
incubated with GSH for 1Omin. The closed and open 
symbols represent experiments with two preparations of 
GSH transferase B. Assays were carried out as described 
in the text using a mixture of equal amounts of the two 
forms of GSH S-transferase B (no significant differences 
were obtained using either form by itself). 
of the reaction of cholesterol a-oxide with 
transferase B is shown in fig. 1. The kinetic pattern 
obtained (fig. lc) is complex and suggests that a 
form of substrate inhibition may occur. This could 
be due to the binding of substrate in a catalytically 
inactive orientation such as is thought to occur 
with electrophilic metabolites of N,N’-dimethyl- 
4-aminoazobenzene [ 19,201. 
The maximum rate obtainable (- 100 pmol . 
mint. mg protein-‘) is low compared with com- 
monly used exogenous ubstrates [13] but it repre- 
sents a considerable stimulation of the non-cataly- 
tic rate which is barely detectable under these assay 
conditions yielding a second-order ate constant of 
3 x 10-r’ 1. mol-’ . min-‘. 
Since cholesterol a-oxide has been shown to be 
a significant product of microsomal ipid peroxida- 
tion [B] and occurs in human sera [21], it is possible 
that the transferase-catalysed conjugation with 
GSH constitutes a detoxication pathway in vivo. 
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